## September 2019
**[Annotated HIV2 resistance reference library](/pages/refLib/HIV2.html)**

**Database update:**
- HIVDB: 33 new studies entered 
- GenBank: 73 new GenBank submissions imported

## August 2019
**Update to HIVDB phenotype queries:**
- Retrieved datasets downloadable as tab-delimited file

**Update of Signature APOBEC mutations and other lists**
- First time since 2016 we updated the list of signature APOBEC mutations and the list of APOBEC context drug resistance mutations. ([list & rules](/page/apobecs/))
- The usual and unusual mutations list were updated according to the latest HIVDB database.
- The Sierra program version has been updated to 2.3.3 (2019-08-13) accordingly to refect the above two updates.

## July 2019
**ACTG 5275 Clinical Trial [Dataset](/pages/clinicalStudyData/ACTG5275.html):**
- Lennox JL, et al., Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. [Ann Intern Med. 2014 Oct 7;161(7):461-71](https://annals.org/aim/fullarticle/1911116/efficacy-tolerability-3-nonnucleoside-reverse-transcriptase-inhibitor-sparing-antiretroviral-regimens)

**"Amino Acid Prevalence of HIV-1 pol Mutations by Direct PCR and Single Genome Sequencing" published in [AIDS Res Human Retrovirus](https://www.liebertpub.com/doi/abs/10.1089/AID.2018.0289)**
- Contains meta-analysis of data from the [HIV-1 pol Single Genome Sequence Database page](/project/sgs/)

## June 2019
**[Interactive map](/page/surveillance-map/) of HIV-1 drug resistance rates in untreated populations:**
- Updated to reflect published studies in GenBank from 2014-2018; 442 studies of 95,024 persons

**Provisional list of INSTI surveillance DRMs (SDRMs):**
- [Calibrated Population Resistance (CPR)](/cpr/) updated with option to upload IN sequences with mutation prevalence determined using INSTI SDRMs
- [Manuscript](/pages/pdf/Tzou.2019.JAC.pdf) submitted describing the derivation of the list of INSTI SDRMs

**"A systematic review of the genetic mechanisms of dolutegravir resistance" published in [J Antimicrob Chemother](https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkz256/5529201)**

**Update to most HIVDB queries:**
- Retrieved datasets downloadable as either fasta file or tab-delimited file

## April 2019
**Updated release of [Steps and Criteria for Classifying Unusual Mutations](https://github.com/hivdb/hivfacts)**

**"National and International Dimensions of Human Immunodeficiency Virus-1 Sequence Clusters in a Northern California Clinical Cohort." published in [Open Forum Infect Dis](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6483754/)**

**"Multiplex Solid-Phase Melt Curve Analysis for the Point-of-Care Detection of HIV-1 Drug Resistance." published in [J Mol Diagn](https://www.sciencedirect.com/science/article/pii/S1525157818302745?via%3Dihub)**

**ACTG 5208 Clinical Trial [Dataset](/pages/clinicalStudyData/ACTG5208.html):**
- Lockman S, et al., Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. [PLoS Med. 2012;9(6):e1001236](https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1001236)

## March 2019
**Update to HIVDB phenotype queries:**
- added HIV2 phenotypes

## February 2019
**[Annotated dolutegravir (DTG) resistance reference library](/pages/refLib/DTG.html)**

**[HIVDB Algorithm version 8.8](/page/algorithm-updates/#version.8.8.update.2019-02-13)**
- Updated INSTI and NNRTI notes
- Updated Major HIV Drug Resistance Mutations [PDF handout](/assets/media/resistance-mutation-handout-feb2019.b0204a57.pdf)


